Pharma Intelligence Award Japan 2022 Commemorative Webinar “PPI Inhibition by Small Molecules: A New Drug Discovery Paradigm”
PRISM BioLab’s proprietary drug discovery platform, PepMetics®, is a technology that enables the control of protein-protein interactions by small molecules with a unique peptide-mimicking backbone, potentially creating a new drug discovery paradigm.
In this webinar, Dai Takehara, President of PRISM BioLab, will introduce the PepMetics® technology and share his experiences in managing a biotech startup, including the status of collaboration with many global pharmaceutical companies, partnering, fundraising and organizational management to realize a new drug discovery paradigm.
Date & Time： November 9, 2022 (Wed.) 16:00-17:00 JST
Format: Online (Zoom)
Language: Japanese
Participation Fee: Free of charge
